Business Wire

FOURKITES

16.12.2021 11:43:07 CET | Business Wire | Press release

Share
FourKites Closes a Record-Breaking 2021 at the Forefront of Supply Chain Visibility in Europe

FourKites® , the world’s leading real-time supply chain visibility platform , today announced a year of record growth as the company executed on its vision to optimise global supply chains with real-time visibility data and machine learning.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211216005527/en/

In 2021, the company saw triple-digit growth in total shipments; drove 50% growth in new customers across all industries – including Barilla Group, Beyond Meat, Cardinal Health, Haworth, LyondellBasell, McCain Foods, Roehm, Rove Concepts and Yamaha Motors. It also significantly expanded its carrier network and extended real-time visibility to more than 2,800 ports and 2.5 million facilities worldwide.

Key to its growth in 2021 was FourKites’ significant expansion in Europe. The company grew its European carrier network across carriers of all sizes, and added tangible business value with new offerings that enabled European carriers, forwarders and shippers to connect and collaborate on the world’s most trusted supply chain visibility platform. Specifically, in 2021 FourKites saw:

  • 148% growth in European shipment volume, having tracked over 112 billion miles and computed over 5 billion estimated times of arrival globally
  • 2X increase in new European customers
  • 35% growth of its carrier network, and 110% growth of the number of European carriers on FourKites’ Premier Carrier List
  • 50% growth in the number of EMEA ports and 118% growth in the number of facilities tracked per month
  • The appointment of industry veterans Marc Boileau as Senior Vice President, Sales and Carrier Operations, EMEA, and Oleskii Kosenko as Director Carrier Network Operations, EMEA to accelerate regional growth momentum among both shippers and carriers

Alleviating disruptions with innovative solutions for every mode

Amid another year of constant disruptions, FourKites doubled-down on its customer-driven innovation model, with more than 65 new features resulting from customer feedback. These industry-first capabilities help FourKites users track shipments end-to-end across all modes and geographies, from sourcing to manufacturing to final destination.

These innovations included the patented Smart Forecasted Arrival (SFA) that provides frequent and highly accurate ETAs even for untrackable freight in transit; Dynamic ETA® for Ocean ; Dynamic ETA® for Air ; a major upgrade to Dynamic YardSM ; its new Order Intelligence Hub (OIH), which provides a single-pane-of-glass view of the entire lifecycle of every order; and powerful new collaboration features – including Instant Messaging, an updated CarrierLink mobile app for drivers, and enhancements to Partner Hub , its self-service, secure GPS onboarding solution for brokers and carriers.

Forging powerful new partnerships to accelerate end-to-end visibility

In 2021, FourKites forged new strategic partnerships with global supply chain and technology leaders as it continues to execute on its bold vision for the future of digital supply chains, where automated, interconnected and collaborative supply chains are optimised by real-time visibility data and machine learning.

New partnerships in 2021 include a global partnership with Zebra Technologies Corporation (NASDAQ: ZBRA), in which Zebra is now reselling FourKites’ Dynamic Yard and real-time visibility platform as part of its suite of asset visibility solutions. Additionally, Zebra’s MotionWorks Yard solution has been integrated with FourKites Dynamic Yard and Zebra locationing hardware and professional services to increase the in-yard and over-the-road capabilities of their customers.

“We have seen tremendous growth in Europe over the past year, and we look forward to another year of record-breaking momentum," said FourKites founder and CEO Mathew Elenjickal. "Behind each success and innovation are tenacious and passionate employees, customers, and partners who keep redefining what’s possible. I'm grateful to be part of such an awe-inspiring community.”

FourKites’ market leadership was recognised via several prestigious industry reports, including being named a leader in the 2021 Gartner Magic Quadrant for Real-Time Transportation Visibility Platforms .

Customers and carriers in their own words

“The collaboration that we've talked about in logistics for 20 years is now real. And the better that you can collaborate and integrate with your carriers, the more effective you'll be in delivering to your customer’s expectations, which is in the end, what it's all about. FourKites is more than just track-and-trace, it's about the visibility and how we're going to use it to start to drive efficiencies.”

Paul Avampato, Head of International Logistics, Henkel

“Working with AB InBev’s FourKites platform allows us to offer a better service. FourKites makes it so easy for us to feed GPS data into AB InBev’s platform. And now, thanks to being on FourKites’ Premier Carrier List, we’re confident we’ll get even more business from customers who want excellent visibility into their supply chains.”

Roy van der Heijden, business analyst at Int. transportbedrijf van der Heijden b.v.

“Every day, our carriers automatically share location data with our FourKites platform on hundreds of loads throughout Europe. We are able to track our products minute by minute and, in real time, pass on detailed arrival times to our customers. This means the distributors we supply always know their stock situation and end customers can depend on us to get them the seeds and crop protection they need, when they need them.”

Edmund Jager, Head of Distribution EMEA at Bayer

About FourKites

FourKites® is the #1 supply chain visibility platform in the world, extending visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 2.5 million shipments daily across road, rail, ocean, air, parcel and courier, and reaching 176 countries, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 750 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/ .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye